Racho Jordanov and Rose Lin, the septuagenarian co-founders of Taiwanese biotech company JHL Biotech, were convicted Aug. 26 of conspiring to steal trade secrets related to four Genentech (Roche) blockbuster cancer and cystic-fibrosis drugs. The pair were also found guilty of wire fraud.

DaVita and the dialysis provider’s former CEO Kent Thiry were indicted by a federal grand jury in Denver on charges they conspired with competitors not to hire each other’s key employees, the U.S. Justice Department said on July 15.

Two former executives of Taiwan-based JHL Biotech were indicted on charges of orchestrating the theft of trade secrets from Genentech. The U.S. government also charged the former chief executive officer and chief operating officer of that company with wire fraud and money laundering. 

A Harvard professor arrested earlier this year for failing to disclose ties to China’s Thousand Talents Program was indicted for making false statements to federal authorities regarding that work in Wuhan, China.

Less than a year after Sandoz, the generics arm of Novartis, vowed to fight allegations of being involved in a scheme to manipulate the price of generic drugs along with other drugmakers, the company changed course and agreed to pay a $195 million penalty to the U.S. government.

Indivior Plc lost three-quarters of the company’s stock market value and former parent Reckitt Benckiser also fell after the U.S. Justice Department accused the British drugmaker of illegally boosting prescriptions for the blockbuster opioid addiction treatment Suboxone.

The billionaire founder of Insys Therapeutics Inc. appeared in federal court in Boston to plead not guilty to charges that he participated in a scheme to bribe doctors to prescribe a fentanyl-based cancer pain drug.